Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The LymphEdema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and Impact in Newly Diagnosed Patients

NCT00956670 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT00956670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00956670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The LymphEdema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and Impact in Newly Diagnosed Patients
Lead sponsor
Gynecologic Oncology Group
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2012
Completion date
Not reported
Enrollment
1,055 (actual)
Sites
213

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema, stage ia cervical cancer, stage ia uterine corpus cancer, stage ia vulvar cancer, stage ib cervical cancer, stage ib uterine corpus cancer, stage ib vulvar cancer, stage ii uterine corpus cancer, stage ii vulvar cancer, stage iia cervical cancer, stage iiia vulvar cancer, stage iiib vulvar cancer, stage iiic vulvar cancer, stage ivb vulvar cancer